Immunosuppressive therapy with Certican (everolimus) after lung transplantation.
Phase of Trial: Phase III
Latest Information Update: 22 Apr 2016
At a glance
- Drugs Everolimus (Primary)
- Indications Lung transplant rejection
- Focus Therapeutic Use
- 22 Apr 2016 Results published in the American Journal of Transplantation
- 07 Dec 2011 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
- 07 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.